{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-022755","form_type":"8-K","ticker":"VRCA","cik":"0001660334","company_name":"Verrica Pharmaceuticals Inc.","filed_at":"2023-02-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.044883+00:00","generated_at":"2026-06-20T02:27:49.935064+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"low","headline":"Verrica posts updated corporate presentation; no material specifics disclosed","bullets":["Company furnished an updated corporate presentation under Regulation FD on Feb 2, 2023.","Presentation posted on Verrica's website; no financial or operational guidance provided in filing.","No material new facts available from the exhibit summary provided."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-022755","json":"https://secwatch.observer/filing/0001193125-23-022755.json","markdown":"https://secwatch.observer/filing/0001193125-23-022755.md","text":"https://secwatch.observer/filing/0001193125-23-022755.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1660334/000119312523022755/0001193125-23-022755-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1660334/000119312523022755/d456300d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T02:27:49.935064+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}